Windhover publications - IN VIVO, Start-Up, The RPM Report, and MedTech Insight - provide superior analysis and commentary on health care business strategy, industry deal making, and marketplace trends. Windhover's Strategic Transactions database is the most comprehensive deals database in the life science industry. With the merging of Windhover and FDC Reports, publisher of "The Pink Sheet", MichBio members now also receive discounts on FDC Reports publications and the Inteleos drug database. FDC Reports publications, such as "The Pink Sheet", "The Gray Sheet", PharmAsia News, and Pharmaceutical Approvals Monthly, among others, provide the latest regulatory, legislative, and business news affecting the U.S. drug, biotechnology, medical device, and nonprescription drug industries. Inteleos is an online business intelligence database, designed to help professionals track drug development activity from late-stage preclinical to launch and post-marketing studies. This comprehensive database, which is updated daily, covers 12,000+ drugs from 3,000+ companies.
MichBio Member Benefits:**
- Discounts ranging from 17% to 50% off Windhover's standard published rates on Windhover publications: IN VIVO, Start-Up, The RPM Report, and MedTech Insight (Note: the discount is based on the publication selected)
- Discount of 15% off the standard rate for Windhover's Strategic Transactions database
Publications discounted further when purchased in conjunction with Windhover's Strategic Transactions database
- Discount of 30% off the standard rate for FDC Reports publications: "The Pink Sheet", "The Pink Sheet" Daily, PharmAsia News, "The Gray Sheet", and Pharmaceutical Approvals Monthly
- Discount of 15% off the standard rate for the Inteleos database
**Discounts are for new subscriptions only.
Ida Stepinac • I.Stepinac@Elsevier.com • (203) 838-4401, x128
Also visit Windhover: www.windhover.com and FDC Reports: www.FDCReports.com